Skip to content

Feasibility and Accuracy Analysis of AI-Assisted Gastric Volume Assessment

Feasibility and Accuracy Analysis of AI-Assisted Gastric Volume Assessment

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108998
Enrollment
Unknown
Registered
2025-09-10
Start date
2025-09-10
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric retention

Interventions

Healthy Volunteer Group A: Ingestion of 500 ml of water
Healthy Volunteer Group B:Ingestion of a 200 g hamburger
Healthy Volunteer Group C: Combined ingestion of 300 ml of water and a 200 g hamburger
Outpatient Group A:Administration of 20 ml of defoaming agent (simethicone emulsion)
Outpatient Group B:Administration of 40 ml of defoaming agent (simethicone emulsion)
Outpatient Group C:Administration of 60 ml of defoaming agent (simethicone emulsion)

Sponsors

Sichuan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Healthy volunteer queue Age 18 to 85 years; body weight 45 to 110 kg; height > = 145 cm; Fasting >= 8 hours, no water >= 2 hours; Able to understand the study procedures and sign the informed consent form. (2) Outpatient cohort Age 18 to 85 years; body weight 45 to 110 kg; height > = 145 cm; Fasting >= 8 hours, no water >= 2 hours; Patients who underwent gastroscopy in the gastroenterology department on the day of the experiment; Able to understand the study procedures and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Healthy Volunteer Cohort History of upper gastrointestinal bleeding within the past month; history of gastric surgery or known anatomical abnormalities of the upper gastrointestinal tract; use of medications affecting gastrointestinal motility (e.g., domperidone, mosapride) within the past month; inability to cooperate with ultrasound examination; pregnant and lactating women. (2) Outpatient Cohort History of upper gastrointestinal bleeding within the past month; history of gastric surgery or known anatomical abnormalities of the upper gastrointestinal tract; patients with upper gastrointestinal diseases (e.g., pyloric obstruction or stenosis, gastric tumors, gastric ulcers, severe gastrointestinal distension, diabetic gastroparesis); use of medications affecting gastrointestinal motility (e.g., domperidone, mosapride) within the past month; inability to cooperate with ultrasound examination; pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Gastric ultrasound images;

Countries

China

Contacts

Public ContactQian Lei Yue Liu

Sichuan Provincial People's Hospital

364876168@qq.com+86 189 8070 4707

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026